1-2 of 2
Anargyros Xenocostas
Close
Sort by
Journal Articles

A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia

Clinical Trials & Observations
Lili Aslostovar, Allison L. Boyd, Mohammed Almakadi, Tony J. Collins, Darryl P. Leong, Rommel G. Tirona, Richard B. Kim, Jim A. Julian, Anargyros Xenocostas, Brian Leber, Mark N. Levine, Ronan Foley, Mickie Bhatia
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1935–1945.
https://doi.org/10.1182/bloodadvances.2018015677
Published: 2018
Includes: Supplemental data
Journal Articles

Erythropoiesis-stimulating agents in elderly patients with anemia: response and cardiovascular outcomes

Clinical Trials & Observations
Zachary Gowanlock, Swetha Sriram, Alison Martin, Anargyros Xenocostas, Alejandro Lazo-Langner
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1538–1545.
https://doi.org/10.1182/bloodadvances.2017007559
Published: 2017
Includes: Supplemental data